medibles™ | CBD Personalized

Save 20% On Your First Order Click for details

Our Assessment

You're unique, and your CBD regimen should be too.

That’s why we’ve combined years of research and medical expertise to create our online CBD health  assessment to help you discover what CBD regimen you need throughout your life’s journey.

What we do.

medibles is a next-generation subscription-based platform provider that supplies CBD products such as capsules, concentrates, tinctures, edibles, and more for your health and wellness.

  • Gym
  • Home Office
  • Dispenser
Online Health Assessment

Why we do it.

We aim to improve your experience in taking CBD to enhance the efficacy, quality, efficiency, and safety of taking CBD throughout your life’s journey. You’re unique so your CBD regimen should be too.

How we do it.

We offer a personalized CBD program that provides an online health assessment using our proprietary algorithm, a doctor-recommended CBD regimen routine, and a monthly home delivery service. Our doctors, pharmacists, and other health-care experts on our Medical Advisory Board created an online health assessment algorithm using its combined years of professional expertise, science, and technology. Along with analyzed peer-reviewed scientific studies, current and ongoing research, more than thousands of potential medication interactions, and input provided by you to recommend a monthly personalized CBD dosage regimen delivered to your front door.

Personalized CBD recommendations backed by science and cutting edge technology

Each question is backed by the expertise of our Medical Advisory Board, the latest scientific research, and cutting-edge technology, providing you with the most accurate personalized CBD possible.

We're Here for You.

Get one-on-one support with a medibles bio-health specialist.
Have a question? Reach out to us!

Call, chat, email or see our FAQ section below.

Frequently Asked Questions

CBD, or Cannabidiol, is a nonintoxicating component of the cannabis plant with enormous therapeutic potential. Researchers are currently studying the effects of CBD on a wide range of conditions including chronic pain, insomnia, PTSD, anxiety, epilepsy, dementia, and more.

Much extensive pre-clinical research and some clinical studies have shown that CBD has strong anti-oxidant, anti-inflammatory, anticonvulsant, anti-depressant, anti-psychotic, anti-tumoral, and neuroprotective qualities.

THC stands for tetrahydrocannabinol, the main compound found in marijuana plants. THC is what gives marijuana its psychoactive properties or “high” effects.
Cannabidiol (CBD) has many health benefits, without producing the psychoactive, “euphoric” effects of THC. “Relaxing but not intoxicating” is how some of my patients have described the effect. That said, I did have one patient that felt that a low dose of CBD did make her feel high. This is why I recommend starting with very low dosages.

–CBD or cannabidiol exhibits no effects on humans indicative of any abuse or dependence potential.

–To date, there hasn’t been any evidence of recreational use of CBD or any public health-related issues associated with the use of pure CBD/cannabidiol.

–Chronic use and high doses up to 1,500 mg/day of CBD are reportedly well tolerated in humans.

Cannabinoids (e.g., THC and CBD) are the chemical compounds secreted by cannabis flowers that can affect the human body. They work by imitating compounds our bodies naturally produce, called endocannabinoids, that affect nerve, brain and immune cell activity.

Currently, there are two known primary cannabinoid receptors: CB1 and CB2 receptors. CB1 receptors are located in the central nervous system, and in some peripheral tissues. They affect appetite, muscle control, pain, cognition, thermoregulation, andour stress response. CB2 receptors are primarily found in immune cells, and at a lower density in the central nervous system. CB2 activation is associated with immune function and immune cell proliferation, inflammation, and pain. Although these two cannabinoid receptors have been studied relatively extensively, there are more cannabinoid receptors being examined.

No. CBD is one of many cannabinoids within the hemp plant, but it’s currently the most popular one being researched for potential wellness benefits.
CBD that is extracted from hemp and contains less than 0.3% THC is legal at the federal level with the passage of the Farm Bill in late 2018. Each state also has its own law regarding the legality of CBD and therefore the legality of CBD products can vary from state to state.

Hemp and marijuana are different species of Cannabis sativa and bred for different purposes. Industrial hemp is exclusively produced by Cannabis sativa, while marijuana can be derived from Cannabis sativa or Cannabis indica.

Both hemp and marijuana contain CBD, but there’s a much higher percentage in hemp. Hemp also has much lower levels of THC (less than 0.3%) than the marijuana species.

Industrial hemp is grown to be durable, have very long stalks and as few flowering buds as possible—this can make it easier to extract the high amounts of CBD and smaller amounts of THC. Hemp’s chemical profile means that you can’t get “high” from it, and it is used to create medicinal remedies, food, and oil, as well as other products, including rope, bricks, natural polymers, fiber, clothes, and many more.

Marijuana strains of cannabis are typically smaller, flimsier, and have many flowering buds with the sole purpose of maximizing the concentration of THC. Marijuana is used recreationally and medicinally only.

No, CBD and marijuana come from different plants. They do, however, come from the same species of the cannabis plant. There are three recognized species of cannabis plants—Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Both CBD and marijuana are derived from the Cannabis sativa species. While CBD and marijuana both come from thesame species of the cannabis plant, they are derived from different species of Cannabis sativa. CBD is derived from hemp, while marijuana is derived from the marijuana species.
CBD products must contain less than 0.3% THC to be legal according to Federal Law.